Mallinckrodt Public Limited Company Stock Price and Value Analysis

Should you buy Mallinckrodt Public Limited Company stock? (NYSE:MNK). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This company has wild ups and downs.
  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company pays no dividend.

Inside the MNK Numbers

MNK Price
(Mallinckrodt Public Limited Company stock price per share)
$18.83
[?] PE Ratio versus Sector 97% lower than other Healthcare stocks
[?] PE Ratio versus Industry 98% lower than other Drugs - Generic stocks
[?] Cash Yield -0.41%
[?] Free Cash Flow Jitter 37%

Is Mallinckrodt Public Limited Company Stock on Sale?

Based on our analysis, we believe that you should not buy Mallinckrodt Public Limited Company right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy MNK Stock?

Does Mallinckrodt Public Limited Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.